Ninety One (UK)
ELV icon

Ninety One (UK)’s Elevance Health ELV Stock Holding History

Ninety One (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197M Buy
508,280
+3,359
+0.7% +$1.25M 0.44% 58
2026
Q1 		$148M Buy
504,921
+5,466
+1% +$1.8M 0.34% 66
2025
Q4 		$175M Buy
499,455
+45,380
+10% +$15.3M 0.38% 60
2025
Q3 		$147M Buy
454,075
+72,423
+19% +$22.5M 0.32% 70
2025
Q2 		$148M Buy
381,652
+336
+0.1% +$135K 0.35% 64
2025
Q1 		$166M Sell
381,316
-77,017
-17% -$30.9M 0.46% 57
2024
Q4 		$169M Sell
458,333
-274,161
-37% -$115M 0.45% 53
2024
Q3 		$381M Sell
732,494
-137,098
-16% -$73.2M 1.02% 27
2024
Q2 		$471M Sell
869,592
-34,544
-4% -$18.3M 1.3% 24
2024
Q1 		$469M Buy
904,136
+45,965
+5% +$22.9M 1.32% 22
2023
Q4 		$405M Buy
858,171
+147,103
+21% +$68M 1.2% 25
2023
Q3 		$310M Buy
711,068
+155,449
+28% +$70.5M 0.98% 33
2023
Q2 		$247M Buy
555,619
+39,167
+8% +$18.1M 0.72% 43
2023
Q1 		$237M Sell
516,452
-46,393
-8% -$22.1M 0.74% 43
2022
Q4 		$289M Buy
562,845
+17,741
+3% +$9.01M 0.93% 33
2022
Q3 		$248M Sell
545,104
-27,836
-5% -$13.3M 0.82% 36
2022
Q2 		$276M Buy
572,940
+123,847
+28% +$61.3M 0.82% 38
2022
Q1 		$221M Buy
449,093
+117,161
+35% +$53.6M 0.56% 58
2021
Q4 		$154M Sell
331,932
-230
-0.1% -$96.8K 0.37% 75
2021
Q3 		$124M Sell
332,162
-6,595
-2% -$2.51M 0.32% 81
2021
Q2 		$129M Sell
338,757
-57
-0% -$21.8K 0.34% 82
2021
Q1 		$122M Sell
338,814
-8,885
-3% -$2.86M 0.35% 81
2020
Q4 		$112M Sell
347,699
-2,936
-0.8% -$901K 0.34% 82
2020
Q3 		$94.2M Buy
350,635
+12,338
+4% +$3.32M 0.34% 72
2020
Q2 		$89M Sell
338,297
-27,756
-8% -$7.4M 0.32% 71
2020
Q1 		$83.1M Sell
366,053
-243,006
-40% -$66.2M 0.35% 64
2019
Q4 		$184M Sell
609,059
-17,865
-3% -$4.92M 0.61% 51
2019
Q3 		$151M Sell
626,924
-21,583
-3% -$5.91M 0.59% 52
2019
Q2 		$172M Sell
648,507
-128,022
-16% -$35M 0.66% 47
2019
Q1 		$223M Sell
776,529
-58,507
-7% -$16.9M 0.88% 30
2018
Q4 		$219M Buy
+835,036
New +$230M 0.95% 29
2018
Q2 		– Sell
-37,821
Closed -$8.31M – 270
2018
Q1 		$8.31M Sell
37,821
-47
-0.1% -$11K 0.04% 171
2017
Q4 		$8.52M Sell
37,868
-1,661
-4% -$354K 0.04% 197
2017
Q3 		$7.51M Sell
39,529
-1,305
-3% -$248K 0.03% 208
2017
Q2 		$7.68M Sell
40,834
-27,045
-40% -$4.86M 0.04% 194
2017
Q1 		$11.2M Buy
67,879
+5,002
+8% +$796K 0.06% 178
2016
Q4 		$9.04M Buy
62,877
+388
+0.6% +$52K 0.05% 179
2016
Q3 		$7.83M Sell
62,489
-724
-1% -$93.5K 0.04% 201
2016
Q2 		$8.3M Sell
63,213
-1,190
-2% -$163K 0.04% 199
2016
Q1 		$8.95M Sell
64,403
-2,224
-3% -$297K 0.05% 200
2015
Q4 		$9.29M Buy
66,627
+843
+1% +$116K 0.05% 184
2015
Q3 		$9.21M Sell
65,784
-99,308
-60% -$14.9M 0.06% 177
2015
Q2 		$27.1M Sell
165,092
-27,711
-14% -$4.43M 0.15% 124
2015
Q1 		$29.8M Sell
192,803
-13,427
-7% -$1.91M 0.17% 123
2014
Q4 		$25.9M Sell
206,230
-49,745
-19% -$6.15M 0.16% 123
2014
Q3 		$30.6M Sell
255,975
-324,311
-56% -$37.2M 0.18% 127
2014
Q2 		$62.4M Buy
580,286
+2,795
+0.5% +$288K 0.36% 98
2014
Q1 		$57.5M Buy
577,491
+4,245
+0.7% +$384K 0.38% 88
2013
Q4 		$53M Buy
573,246
+28,495
+5% +$2.53M 0.37% 92
2013
Q3 		$45.5M Sell
544,751
-8,157
-1% -$699K 0.34% 98
2013
Q2 		$45.3M Buy
+552,908
New +$41.4M 0.35% 96

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Ninety One (UK)'s ELV Position: Q2 2026 in Review

Ninety One (UK) increased its Elevance Health (ELV) stake by 0.67% in Q2 2026, buying an estimated $1.25M and bringing the position to 508,280 shares worth $197M. The position accounts for 0.44% of the portfolio, ranked #58.

Ninety One (UK) first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $471M in Q2 2024. 331 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ninety One (UK) held 508,280 shares of Elevance Health worth $197M as of Q2 2026.
  • Ninety One (UK) bought 3,359 Elevance Health shares in Q2 2026, an estimated $1.25M.
  • Elevance Health made up 0.44% of Ninety One (UK)'s portfolio in Q2 2026, its #58 holding.
  • Ninety One (UK) first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Ninety One (UK)'s Elevance Health position peaked at $471M in Q2 2024.
  • 331 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.